Navigation Links
Reportlinker Adds Global In Vitro Diagnostics Market Analysis and Forecasts to 2015
Date:12/1/2009

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

http://www.reportlinker.com/p0166596/Global-In-Vitro-Diagnostics-Market-Analysis-and-Forecasts-to-2015.html

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

Summary

GlobalData's "Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015" report provides key data, information and analysis on the global IVD market. The report provides market landscape, competitive landscape and market trends information on seven market categories including clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the global IVD market to 2015.

- Geographical coverage across 12 major countries which include the US (United States), the UK (United Kingdom), France, Italy, Spain, Canada, Germany, Japan, India, China, Australia and Brazil

- Market segmentation by clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology.

- Market Analysis from 2001 to 2008, including new updated 2008 data.

- Analysis of the leading companies and competitive landscape including 2008 company market share analysis. Key companies covered include F. Hoffmann-La Roche Ltd, Siemens Medical Solutions, Abbott Laboratories, Beckman Coulter, Inc., Biomerieux Sa and Ortho-Clinical Diagnostics Inc.

- Analysis of key IVD pipeline products, new technologies and clinical trials.

- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.

- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the global IVD market.

- Develop a clear knowledge & understanding of the global IVD competitor landscape and how this will change to 2015.

- Identify acquisition opportunities across the global IVD market.

- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Executive Summary

4 Definitions of Markets Covered in This Report

4.1 In Vitro Diagnostics

4.2 Blood Test Reagents

4.3 Clinical Chemistry Test Reagents

4.4 Genetic Test Reagents

4.5 Immunochemistry Test Reagents

4.6 Infectious Immunology Test Reagents

4.7 Instruments

4.8 Microbiology Test Reagents

4.9 Self Testing

5 Global In Vitro Diagnostics

5.1 In Vitro Diagnostics, Global, Overall Revenue ($m), 2000-2015

5.2 In Vitro Diagnostics Market Dynamic

5.3 In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015

5.4 In Vitro Diagnostics, Global, Competitive Landscape

6 In Vitro Diagnostics Cross Country Comparison

6.1 In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015

7 In Vitro Diagnostics In US

7.1 In Vitro Diagnostics, US, Overall Revenue ($m), 2000-2015

7.2 In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015

7.3 In Vitro Diagnostics, US, Distribution Share (2007-2008)

7.4 In Vitro Diagnostics, US, Company Share (2007-2008)

8 In Vitro Diagnostics In Japan

8.1 In Vitro Diagnostics, Japan, Overall Revenue ($m), 2000-2015

8.2 In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015

8.3 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)

8.4 In Vitro Diagnostics, Japan, Company Share (2007-2008)

9 In Vitro Diagnostics In Germany

9.1 In Vitro Diagnostics, Germany, Overall Revenue ($m), 2000-2015

9.2 In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015

9.3 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)

9.4 In Vitro Diagnostics, Germany, Company Share (2007-2008)

10 In Vitro Diagnostics In Italy

10.1 In Vitro Diagnostics, Italy, Overall Revenue ($m), 2000-2015

10.2 In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015

10.3 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)

10.4 In Vitro Diagnostics, Italy, Company Share (2007-2008)

11 In Vitro Diagnostics In France

11.1 In Vitro Diagnostics, France, Overall Revenue ($m), 2000-2015

11.2 In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015

11.3 In Vitro Diagnostics, France, Distribution Share (2007-2008)

11.4 In Vitro Diagnostics, France, Company Share (2007-2008)

12 In Vitro Diagnostics In China

12.1 In Vitro Diagnostics, China, Overall Revenue ($m), 2000-2015

12.2 In Vitro Diagnostics, China, Cross-Category Analysis, 2000-2015

12.3 In Vitro Diagnostics, China, Distribution Share (2007-2008)

12.4 In Vitro Diagnostics, China, Company Share (2007-2008)

13 In Vitro Diagnostics In Spain

13.1 In Vitro Diagnostics, Spain, Overall Revenue ($m), 2000-2015

13.2 In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015

13.3 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)

13.4 In Vitro Diagnostics, Spain, Company Share (2007-2008)

14 In Vitro Diagnostics In UK

14.1 In Vitro Diagnostics, UK, Overall Revenue ($m), 2000-2015

14.2 In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-2015

14.3 In Vitro Diagnostics, UK, Distribution Share (2007-2008)

14.4 In Vitro Diagnostics, UK, Company Share (2007-2008)

15 In Vitro Diagnostics In Brazil

15.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2000-2015

15.2 In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015

15.3 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)

15.4 In Vitro Diagnostics, Brazil, Company Share (2007-2008)

16 In Vitro Diagnostics In Canada

16.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), 2000-2015

16.2 In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015

16.3 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)

16.4 In Vitro Diagnostics, Canada, Company Share (2007-2008)

17 In Vitro Diagnostics In India

17.1 In Vitro Diagnostics, India, Overall Revenue ($m), 2000-2015

17.2 In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015

17.3 In Vitro Diagnostics, India, Distribution Share (2007-2008)

17.4 In Vitro Diagnostics, India, Company Share (2007-2008)

18 In Vitro Diagnostics In Australia

18.1 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2000-2015

18.2 In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015

18.3 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)

18.4 In Vitro Diagnostics, Australia, Company Share (2007-2008)

19 Overview of Key Companies in In Vitro Diagnostics Market

19.1 F. Hoffmann-La Roche Ltd.

19.2 Siemens Healthcare

19.3 Abbott Laboratories

19.4 Beckman Coulter, Inc.

19.5 Ortho-Clinical Diagnostics Inc.

19.6 bioMerieux S.A.

20 Financial Deals Landscape

20.1 Financial Deal Analysis Deal Type

20.2 Financial Deal Analysis - Deal Value and Volume

20.3 Merger

20.4 Acquisition

20.5 Partnerships

21 Recent Developments

21.1 Strategy And Business Planning

21.2 Legal and Regulatory

21.3 Government and Public Interest

21.4 Other Significant Developments

22 Appendix

22.1 GlobalData Research Methodology

22.2 Secondary Research

22.3 Primary Research

22.4 Models

22.5 Forecasts

22.6 Expert Panel Validation

22.7 Currency Conversion

22.8 Contact Us

22.9 Disclaimer

1.1 List of Tables

Table 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008 36

Table 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015 38

Table 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015 42

Table 4: In Vitro Diagnostics, Global, Company share by Revenue ($m), 2007-2008 44

Table 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 - 2015 46

Table 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015 48

Table 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008 50

Table 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015 52

Table 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015 54

Table 10: Clinical Chemistry, US, Distribution Share by Revenue ($m), 2007-2008 55

Table 11: Genetic Testing, US, Distribution Share by Revenue ($m), 2007-2008 55

Table 12: Haematology, US, Distribution Share by Revenue ($m), 2007-2008 56

Table 13: Histology And Cytology, US, Distribution Share by Revenue ($m), 2007-2008 56

Table 14: Immuno Chemistry, US, Distribution Share by Revenue ($m), 2007-2008 57

Table 15: Infectious Immunology, US, Distribution Share by Revenue ($m), 2007-2008 57

Table 16: Microbiology Culture, US, Distribution Share by Revenue ($m), 2007-2008 58

Table 17: In Vitro Diagnostics, US, Company Share by Revenue ($m), 2008-2008 60

Table 18: Clinical Chemistry, US, Company Share by Revenue ($m), 2007-2008 62

Table 19: Genetic Testing, US, Company Share by Revenue ($m), 2007-2008 64

Table 20: Haematology, US, Company Share by Revenue ($m), 2007-2008 65

Table 21: Histology And Cytology, US, Company Share by Revenue ($m), 2007-2008 66

Table 22: Immuno Chemistry, US, Company Share by Revenue ($m), 2007-2008 68

Table 23: Infectious Immunology, US, Company Share by Revenue ($m), 2007-2008 70

Table 24: Microbiology Culture, US, Company Share by Revenue ($m), 2007-2008 71

Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008 73

Table 26: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015 75

Table 27: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015 77

Table 28: Clinical Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008 78

Table 29: Genetic Testing, Japan, Distribution Share by Revenue ($m), 2007-2008 78

Table 30: Haematology, Japan, Distribution Share by Revenue ($m), 2007-2008 79

Table 31: Histology And Cytology, Japan, Distribution Share by Revenue ($m), 2007-2008 79

Table 32: Immuno Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008 80

Table 33: Infectious Immunology, Japan, Distribution Share by Revenue ($m), 2007-2008 80

Table 34: Microbiology Culture, Japan, Distribution Share by Revenue ($m), 2007-2008 81

Table 35: In Vitro Diagnostics, Japan, Company Share by Revenue ($m), 2008-2008 83

Table 36: Clinical Chemistry, Japan, Company Share by Revenue ($m), 2007-2008 85

Table 37: Genetic Testing, Japan, Company Share by Revenue ($m), 2007-2008 87

Table 38: Haematology, Japan, Company Share by Revenue ($m), 2007-2008 89

Table 39: Histology And Cytology, Japan, Company Share by Revenue ($m), 2007-2008 91

Table 40: Immuno Chemistry, Japan, Company Share by Revenue ($m), 2007-2008 93

Table 41: Infectious Immunology, Japan, Company Share by Revenue ($m), 2007-2008 95

Table 42: Microbiology Culture, Japan, Company Share by Revenue ($m), 2007-2008 97

Table 43: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008 99

Table 44: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015 101

Table 45: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 103

Table 46: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008 104

Table 47: Genetic Testing, Germany, Distribution Share by Revenue ($m), 2007-2008 104

Table 48: Haematology, Germany, Distribution Share by Revenue ($m), 2007-2008 105

Table 49: Histology And Cytology, Germany, Distribution Share by Revenue ($m), 2007-2008 105

Table 50: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008 106

Table 51: Infectious Immunology, Germany, Distribution Share by Revenue ($m), 2007-2008 106

Table 52: Microbiology Culture, Germany, Distribution Share by Revenue ($m), 2007-2008 107

Table 53: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), 2008-2008 109

Table 54: Clinical Chemistry, Germany, Company Share by Revenue ($m), 2007-2008 111

Table 55: Genetic Testing, Germany, Company Share by Revenue ($m), 2007-2008 112

Table 56: Haematology, Germany, Company Share by Revenue ($m), 2007-2008 114

Table 57: Histology And Cytology, Germany, Company Share by Revenue ($m), 2007-2008 116

Table 58: Immuno Chemistry, Germany, Company Share by Revenue ($m), 2007-2008 118

Table 59: Infectious Immunology, Germany, Company Share by Revenue ($m), 2007-2008 120

Table 60: Microbiology Culture, Germany, Company Share by Revenue ($m), 2007-2008 122

Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008 124

Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015 126

Table 63: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015 128

Table 64: Clinical Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008 129

Table 65: Genetic Testing, Italy, Distribution Share by Revenue ($m), 2007-2008 129

Table 66: Haematology, Italy, Distribution Share by Revenue ($m), 2007-2008 130

Table 67: Histology And Cytology, Italy, Distribution Share by Revenue ($m), 2007-2008 130

Table 68: Immuno Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008 131

Table 69: Infectious Immunology, Italy, Distribution Share by Revenue ($m), 2007-2008 131

Table 70: Microbiology Culture, Italy, Distribution Share by Revenue ($m), 2007-2008 132

Table 71: In Vitro Diagnostics, Italy, Company Share by Revenue ($m), 2008-2008 134

Table 72: Clinical Chemistry, Italy, Company Share by Revenue ($m), 2007-2008 136

Table 73: Genetic Testing, Italy, Company Share by Revenue ($m), 2007-2008 138

Table 74: Haematology, Italy, Company Share by Revenue ($m), 2007-2008 140

Table 75: Histology And Cytology, Italy, Company Share by Revenue ($m), 2007-2008 142

Table 76: Immuno Chemistry, Italy, Company Share by Revenue ($m), 2007-2008 144

Table 77: Infectious Immunology, Italy, Company Share by Revenue ($m), 2007-2008 146

Table 78: Microbiology Culture, Italy, Company Share by Revenue ($m), 2007-2008 148

Table 79: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2000-2008 150

Table 80: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2008-2015 152

Table 81: In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015 154

Table 82: Clinical Chemistry, France, Distribution Share by Revenue ($m), 2007-2008 155

Table 83: Genetic Testing, France, Distribution Share by Revenue ($m), 2007-2008 155

Table 84: Haematology, France, Distribution Share by Revenue ($m), 2007-2008 156

Table 85: Histology And Cytology, France, Distribution Share by Revenue ($m), 2007-2008 156

Table 86: Immuno Chemistry, France, Distribution Share by Revenue ($m), 2007-2008 157

Table 87: Infectious Immunology, France, Distribution Share by Revenue ($m), 2007-2008 157

Table 88: Microbiology Culture, France, Distribution Share by Revenue ($m), 2007-2008 158

Table 89: In Vitro Diagnostics, France, Company Share by Revenue ($m), 2008-2008 160

Table 90: Clinical Chemistry, France, Company Share by Revenue ($m), 2007-2008 162

Table 91: Genetic Testing, France, Company Share by Revenue ($m), 2007-2008 164

Table 92: Haematology, France, Company Share by Revenue ($m), 2007-2008 166

Table 93: Histology And Cytology, France, Company Share by Revenue ($m), 2007-2008 167

Table 94: Immuno Chemistry, France, Company Share by Revenue ($m), 2007-2008 169

Table 95: Infectious Immunology, France, Company Share by Revenue ($m), 2007-2008 171

Table 96: Microbiology Culture, France, Company Share by Revenue ($m), 2007-2008 173

Table 97: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2000-2008 175

Table 98: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2008-2015 177

Table 99: In Vitro Diagnostics, China, Cross-Category Analysis, 2000-2015 179

Table 100: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2007-2008 180

Table 101: Genetic Testing, China, Distribution Share by Revenue ($m), 2007-2008 180

Table 102: Haematology, China, Distribution Share by Revenue ($m), 2007-2008 181

Table 103: Histology And Cytology, China, Distribution Share by Revenue ($m), 2007-2008 181

Table 104: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2007-2008 182

Table 105: Infectious Immunology, China, Distribution Share by Revenue ($m), 2007-2008 182

Table 106: Microbiology Culture, China, Distribution Share by Revenue ($m), 2007-2008 183

Table 107: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2008 185

Table 108: Clinical Chemistry, China, Company Share by Revenue ($m), 2007-2008 187

Table 109: Genetic Testing, China, Company Share by Revenue ($m), 2007-2008 189

Table 110: Haematology, China, Company Share by Revenue ($m), 2007-2008 191

Table 111: Histology And Cytology, China, Company Share by Revenue ($m), 2007-2008 193

Table 112: Immuno Chemistry, China, Company Share by Revenue ($m), 2007-2008 195

Table 113: Infectious Immunology, China, Company Share by Revenue ($m), 2007-2008 197

Table 114: Microbiology Culture, China, Company Share by Revenue ($m), 2007-2008 199

Table 115: In Vitro Diagnostics, Spain, Overall Revenue ($m), Historic, 2000-2008 201

Table 116: In Vitro Diagnostics, Spain, Overall Revenue ($m), Forecast, 2008-2015 203

Table 117: In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015 205

Table 118: Clinical Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008 206

Table 119: Genetic Testing, Spain, Distribution Share by Revenue ($m), 2007-2008 206

Table 120: Haematology, Spain, Distribution Share by Revenue ($m), 2007-2008 207

Table 121: Histology and Cytology, Spain, Distribution Share by Revenue ($m), 2007-2008 207

Table 122: Immuno Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008 208

Table 123: Infectious Immunology, Spain, Distribution Share by Revenue ($m), 2007-2008 208

Table 124: Microbiology Culture, Spain, Distribution Share by Revenue ($m), 2007-2008 209

Table 125: In Vitro Diagnostics, Spain, Company Share by Revenue ($m), 2008-2008 211

Table 126: Clinical Chemistry, Spain, Company Share by Revenue ($m), 2007-2008 213

Table 127: Genetic Testing, Spain, Company Share by Revenue ($m), 2007-2008 215

Table 128: Haematology, Spain, Company Share by Revenue ($m), 2007-2008 217

Table 129: Histology And Cytology, Spain, Company Share by Revenue ($m), 2007-2008 219

Table 130: Immuno Chemistry, Spain, Company Share by Revenue ($m), 2007-2008 221

Table 131: Infectious Immunology, Spain, Company Share by Revenue ($m), 2007-2008 223

Table 132: Microbiology Culture, Spain, Company Share by Revenue ($m), 2007-2008 225

Table 133: In Vitro Diagnostics, UK, Overall Revenue ($m), Historic, 2000-2008 227

Table 134: In Vitro Diagnostics, UK, Overall Revenue ($m), Forecast, 2008-2015 229

Table 135: In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-2015 231

Table 136: Clinical Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008 232

Table 137: Genetic Testing, UK, Distribution Share by Revenue ($m), 2007-2008 232

Table 138: Haematology, UK, Distribution Share by Revenue ($m), 2007-2008 233

Table 139: Histology And Cytology, UK, Distribution Share by Revenue ($m), 2007-2008 233

Table 140: Immuno Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008 234

Table 141: Infectious Immunology, UK, Distribution Share by Revenue ($m), 2007-2008 234

Table 142: Microbiology Culture, UK, Distribution Share by Revenue ($m), 2007-2008 235

Table 143: In Vitro Diagnostics, UK, Company Share by Revenue ($m), 2008-2008 237

Table 144: Clinical Chemistry, UK, Company Share by Revenue ($m), 2007-2008 239

Table 145: Genetic Testing, UK, Company Share by Revenue ($m), 2007-2008 240

Table 146: Haematology, UK, Company Share by Revenue ($m), 2007-2008 242

Table 147: Histology and Cytology, UK, Company Share by Revenue ($m), 2007-2008 244

Table 148: Immuno Chemistry, UK, Company Share by Revenue ($m), 2007-2008 246

Table 149: Infectious Immunology, UK, Company Share by Revenue ($m), 2007-2008 248

Table 150: Microbiology Culture, UK, Company Share by Revenue ($m), 2007-2008 250

Table 151: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Historic, 2000-2008 252

Table 152: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Forecast, 2008-2015 254

Table 153: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015 256

Table 154: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008 257

Table 155: Genetic Testing, Brazil, Distribution Share by Revenue ($m), 2007-2008 257

Table 156: Haematology, Brazil, Distribution Share by Revenue ($m), 2007-2008 258

Table 157: Histology and Cytology, Brazil, Distribution Share by Revenue ($m), 2007-2008 258

Table 158: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008 259

Table 159: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), 2007-2008 259

Table 160: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), 2007-2008 260

Table 161: In Vitro Diagnostics, Brazil, Company Share by Revenue ($m), 2008-2008 262

Table 162: Clinical Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008 264

Table 163: Genetic Testing, Brazil, Company Share by Revenue ($m), 2007-2008 266

Table 164: Haematology, Brazil, Company Share by Revenue ($m), 2007-2008 268

Table 165: Histology and Cytology, Brazil, Company Share by Revenue ($m), 2007-2008 270

Table 166: Immuno Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008 272

Table 167: Infectious Immunology, Brazil, Company Share by Revenue ($m), 2007-2008 274

Table 168: Microbiology Culture, Brazil, Company Share by Revenue ($m), 2007-2008 276

Table 169: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2000-2008 278

Table 170: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2008-2015 280

Table 171: In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015 282

Table 172: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008 283

Table 173: Genetic Testing, Canada, Distribution Share by Revenue ($m), 2007-2008 283

Table 174: Haematology, Canada, Distribution Share by Revenue ($m), 2007-2008 284

Table 175: Histology And Cytology, Canada, Distribution Share by Revenue ($m), 2007-2008 284

Table 176: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008 285

Table 177: Infectious Immunology, Canada, Distribution Share by Revenue ($m), 2007-2008 285

Table 178: Microbiology Culture, Canada, Distribution Share by Revenue ($m), 2007-2008 286

Table 179: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), 2008-2008 288

Table 180: Clinical Chemistry, Canada, Company Share by Revenue ($m), 2007-2008 290

Table 181: Genetic Testing, Canada, Company Share by Revenue ($m), 2007-2008 292

Table 182: Haematology, Canada, Company Share by Revenue ($m), 2007-2008 294

Table 183: Histology and Cytology, Canada, Company Share by Revenue ($m), 2007-2008 296

Table 184: Immuno Chemistry, Canada, Company Share by Revenue ($m), 2007-2008 298

Table 185: Infectious Immunology, Canada, Company Share by Revenue ($m), 2007-2008 300

Table 186: Microbiology Culture, Canada, Company Share by Revenue ($m), 2007-2008 302

Table 187: In Vitro Diagnostics, India, Overall Revenue ($m), Historic, 2000-2008 304

Table 188: In Vitro Diagnostics, India, Overall Revenue ($m), Forecast, 2008-2015 306

Table 189: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015 308

Table 190: Clinical Chemistry, India, Distribution Share by Revenue ($m), 2007-2008 309

Table 191: Genetic Testing, India, Distribution Share by Revenue ($m), 2007-2008 309

Table 192: Haematology, India, Distribution Share by Revenue ($m), 2007-2008 310

Table 193: Histology and Cytology, India, Distribution Share by Revenue ($m), 2007-2008 310

Table 194: Immuno Chemistry, India, Distribution Share by Revenue ($m), 2007-2008 311

Table 195: Infectious Immunology, India, Distribution Share by Revenue ($m), 2007-2008 311

Table 196: Microbiology Culture, India, Distribution Share by Revenue ($m), 2007-2008 312

Table 197: In Vitro Diagnostics, India, Company Share by Revenue ($m), 2008-2008 314

Table 198: Clinical Chemistry, India, Company Share by Revenue ($m), 2007-2008 316

Table 199: Genetic Testing, India, Company Share by Revenue ($m), 2007-2008 318

Table 200: Haematology, India, Company Share by Revenue ($m), 2007-2008 320

Table 201: Histology and Cytology, India, Company Share by Revenue ($m), 2007-2008 322

Table 202: Immuno Chemistry, India, Company Share by Revenue ($m), 2007-2008 324

Table 203: Infectious Immunology, India, Company Share by Revenue ($m), 2007-2008 326

Table 204: Microbiology Culture, India, Company Share by Revenue ($m), 2007-2008 328

Table 205: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2000-2008 330

Table 206: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2008-2015 332

Table 207: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015 334

Table 208: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008 335

Table 209: Genetic Testing, Australia, Distribution Share by Revenue ($m), 2007-2008 335

Table 210: Haematology, Australia, Distribution Share by Revenue ($m), 2007-2008 336

Table 211: Histology and Cytology, Australia, Distribution Share by Revenue ($m), 2007-2008 336

Table 212: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008 337

Table 213: Infectious Immunology, Australia, Distribution Share by Revenue ($m), 2007-2008 337

Table 214: Microbiology Culture, Australia, Distribution Share by Revenue ($m), 2007-2008 338

Table 215: In Vitro Diagnostics, Australia, Company Share by Revenue ($m), 2008-2008 340

Table 216: Clinical Chemistry, Australia, Company Share by Revenue ($m), 2007-2008 342

Table 217: Genetic Testing, Australia, Company Share by Revenue ($m), 2007-2008 344

Table 218: Haematology, Australia, Company Share by Revenue ($m), 2007-2008 346

Table 219: Histology and Cytology, Australia, Company Share by Revenue ($m), 2007-2008 347

Table 220: Immuno Chemistry, Australia, Company Share by Revenue ($m), 2007-2008 349

Table 221: Infectious Immunology, Australia, Company Share by Revenue ($m), 2007-2008 351

Table 222: Microbiology Culture, Australia, Company Share by Revenue ($m), 2007-2008 353

Table 223: Abbott Laboratories Pipeline Products by Equipment Type 356

Table 224: Abbott Laboratories Pipeline Products By Development Stage 356

Table 225: Abbott Laboratories Pipeline Products By Therapy Area 357

Table 226: Beckman Coulter, Inc. Pipeline Products by Equipment Type 359

Table 227: Beckman Coulter, Inc. Pipeline Products By Development Stage 360

Table 228: Beckman Coulter, Inc. Pipeline Products By Therapy Area 361

Table 229: Beckman Coulter, Inc. Pipeline Products By News Summary 361

Table 230: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 362

Table 231: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 363

Table 232: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 363

Table 233: ViraCor Laboratories To Merge With IBT Laboratories 367

Table 234: Bookham Merges With AVANEX To Form Oclaro 368

Table 235: Sorrento Therapeutics Completes Reverse Acquisition With QuikByte Software 370

Table 236: Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital 371

Table 237: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 373

Table 238: PerkinElmer Acquires Surendra Genetic Labs 374

Table 239: Cell Biosciences Enters Into Agreement To Acquire Alpha Innotech 375

Table 240: Thermo Fisher Scientific To Acquire B.R.A.H.M.S. 377

Table 241: Danaher To Acquire Remaining 50% Interest In AB SCIEX 378

Table 242: Danaher To Acquire Analytical Technologies From MDS 379

Table 243: Dia-B Tech Terminates Acquisition Of Pallane Medical 381

Table 244: Quest Diagnostics Acquires Caritas Medical Laboratories From Caritas Christi Health Care 382

Table 245: Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 383

Table 246: Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 385

Table 247: Agilent Technologies To Acquire Varian 387

Table 248: Bostwick To Acquire CBI Services And Fairfax Identity Laboratories From Commonwealth 388

Table 249: Enigma Diagnostics To Receive Equity Investment From GlaxoSmithKline 390

Table 250: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America 391

Table 251: Sonic Healthcare To Acquire 100% Of Lademannbogen Laboratory 392

Table 252: Adeona Pharmaceuticals Completes Acquisition Of Hartlab 393

Table 253: ICON Acquires Veeda Laboratories From Veeda Clinical Research 394

Table 254: Barclays Bank And The Royal Bank of Scotland Receives Approval To Acquire USP Group 395

Table 255: TOPTICA Photonics Acquires TILL Photonics From Agilent Technologies 396

Table 256: QIAGEN Enters Into An Agreement With Roche And Idaho Technology 397

Table 257: AbD Serotec Enters Into Research Collaboration With Foundation for Innovative New Diagnostics 398

Table 258: Warnex Signs Distribution Agreement With Biron-Laboratoire medical 399

Table 259: Immunodiagnostic Systems Holdings Enters Into Licensing Agreement With Biosignatures 400

Table 260: Accumetrics Enters Into Agreement With Grifols 401

Table 261: Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics 402

Table 262: IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio 403

Table 263: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories 404

Table 264: Epigenomics Signs Licensing Agreement With ARUP Laboratories 405

Table 265: Horizon Discovery Enters Into An Agreement With Newcastle University 406

Table 266: Warnex Signs Distribution Agreement With Rosetta Genomics 407

Table 267: Lab21 Enters Into Distribution Agreement With AdnaGen 408

Table 268: Celera Enters Into Agreement With Aurora Health Care 409

Table 269: The Addario Lung Cancer Medical Institute Enters Into An Agreement With Response Genetics 410

Table 270: QuantRx Biomedical Enters Into Joint Venture Agreement With NuRx Pharmaceuticals 411

Table 271: DxS Signs Cross-Licensing Agreement With Epigenomics 412

Table 272: Enigma Diagnostics Enters Into An Agreement With Roche Molecular Systems 413

Table 273: IVAX Diagnostics Amends Its Distribution Agreement With IMMCO Diagnostics 414

Table 274: IVAX Diagnostics Signs Distribution Agreement With Augurix 415

Table 275: Prodesse Enters Into A licensing Agreement With Abbott Laboratories 416

Table 276: USD to Local Currency, Average Exchange Rate 2008 466

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008 35

Figure 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015 37

Figure 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015 41

Figure 4: In Vitro Diagnostics, Global, Company share (%), 2008 43

Figure 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 - 2015 45

Figure 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015 47

Figure 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008 49

Figure 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015 51

Figure 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015 53

Figure 10: In Vitro Diagnostics, US, Company Share (%), 2008 59

Figure 11: Clinical Chemistry, US, Company Share (%), 2008 61

Figure 12: Genetic Testing, US, Company Share (%), 2008 63

Figure 13: Haematology, US, Company Share (%), 2008 65

Figure 14: Histology And Cytology, US, Company Share (%), 2008 66

Figure 15: Immuno Chemistry, US, Company Share (%), 2008 67

Figure 16: Infectious Immunology, US, Company Share (%), 2008 69

Figure 17: Microbiology Culture, US, Company Share (%), 2008 71

Figure 18: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008 72

Figure 19: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015 74

Figure 20: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015 76

Figure 21: In Vitro Diagnostics, Japan, Company Share (%), 2008 82

Figure 22: Clinical Chemistry, Japan, Company Share (%), 2008 84

Figure 23: Genetic Testing, Japan, Company Share (%), 2008 86

Figure 24: Haematology, Japan, Company Share (%), 2008 88

Figure 25: Histology And Cytology, Japan, Company Share (%), 2008 90

Figure 26: Immuno Chemistry, Japan, Company Share (%), 2008 92

Figure 27: Infectious Immunology, Japan, Company Share (%), 2008 94

Figure 28: Microbiology Culture, Japan, Company Share (%), 2008 96

Figure 29: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008 98

Figure 30: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015 100

Figure 31: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 102

Figure 32: In Vitro Diagnostics, Germany, Company Share (%), 2008 108

Figure 33: Clinical Chemistry, Germany, Company Share (%), 2008 110

Figure 34: Genetic Testing, Germany, Company Share (%), 2008 112

Figure 35: Haematology, Germany, Company Share (%), 2008 113

Figure 36: Histology And Cytology, Germany, Company Share (%), 2008 115

Figure 37: Immuno Chemistry, Germany, Company Share (%), 2008 117

Figure 38: Infectious Immunology, Germany, Company Share (%), 2008 119

Figure 39: Microbiology Culture, Germany, Company Share (%), 2008 121

Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008 123

Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015 125

Figure 42: In V

To order this report:

In Vitro Diagnostic Industry: Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show where ... see the most incredible gardens and home improvement experts that attend this amazing show. ... - 700 14th St. Denver CO, is an exciting event that Performance Mobility has ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
(Date:2/7/2016)... Dallas, Texas (PRWEB) , ... February 07, 2016 ... ... its new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and ... , MyDecision™ combines three elements to cut the cost of providing employee healthcare ...
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  HemaFlo Therapeutics, Inc. announced today that the United ... Number 9,119,880 covering the use of NephroFlow to treat acute ... HemaFlo,s founder, said, "We are pleased to secure our rights ... Peterson , PhD, HemaFlo,s founder, said, "We are pleased to ... --> Dale Peterson , PhD, HemaFlo,s founder, said, ...
(Date:2/8/2016)... Feb. 8, 2016 Palatin Technologies, Inc. ... receptor-specific peptide therapeutics for the treatment of diseases ... announced today that the United States Patent and ... Allowance for U.S. Patent Application Serial Number 14/313,258 ... methods of treating female sexual dysfunction using the ...
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: AMGN ... Annual Global Healthcare Conference at 9:15 a.m. ET on Wednesday, ... . David W. Meline , executive vice president and ... Live audio of the presentation can be accessed from the ... A replay of the webcast will also be available on ...
Breaking Medicine Technology: